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Primary degenerative mitral regurgitation (MR) is caused by abnormality of one or more components 
of the valve apparatus, whereas functional MR is a left ventricular (LV) disease. Mitral valve (MV) 
surgery is required to address the primary process in degenerative MR (DMR), but the timing of MV 
surgery is controversial in asymptomatic patients. The “watchful waiting” strategy is dictated by a 
timely LV dysfunction recognition. The guidelines recommend MV surgery in asymptomatic patients 
with LV ejection fraction (EF) <60%, LV end-systolic diameter 40 to 45 mm, new-onset atrial fibrillation, 
resting systolic pulmonary artery pressure (sPAP) exceeding 50 mmHg, or if surgical risk is low with 
high likelihood of durable MV repair1.
Current accepted echocardiographic measurements of LV function are not sensitive enough for early 
myocardial injury detection since end-systolic dimensions and EF are affected by the different loading 
conditions in MR. The key is to identify hemodynamic consequences early in MR time course so that 
timely surgery may reverse them before becoming irreversible2. Studies struggle on identifying other 
parameters or methods that could detect subclinical LV systolic dysfunction and predict postoperative 
outcomes such as:  1) brain natriuretic peptide (BNP) (there is no specific BNP cutoff of BNP for inter-
vention, but a serial increase in  BNP may reflect LV dysfunction and increased reliance on preload 
reserve in maintaining cardiac output); 2) LV global longitudinal strain (GLS) (a sensitive method for 
early detection of LV dysfunction, independently associated with mortality, add incremental data to 
surgical timing, with cutoffs −17.9% and −21.7% shown in studies that differentiate patients at higher 
risk, and with the possibility to detect relative change of GLS from baseline as in cardio-oncology); 3) 
left atrial size and strain; 4) echocardiographic exercise testing (good contractile reserve measured 
by LVEF and LV GLS and preserved exercise capacity without sPAP or MR worsening are reassuring 
parameters for a beneficial outcome); 5) cardiac magnetic resonance imaging (it can potentially reclas-
sify MR severity providing valuable data on LV function and volumes)1-3.
Lastly, determination of proper timing for DMR surgery remains challenging and requires more stud-
ies.
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